Fifth Third Bancorp’s VanEck Biotech ETF BBH Stock Holding History

Fifth Third Bancorp’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$137K	Hold	675	–	–	﹤0.01%	2808
2026 Q1	$127K	Buy	+675	New	+$130K	﹤0.01%	2789
2015 Q3	–	Sell	-176	Closed	-$24K	–	2895
2015 Q2	$24K	Buy	+176	New	+$23.4K	﹤0.01%	1713

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fifth Third Bancorp's BBH Position: Q2 2026 in Review

Fifth Third Bancorp held its VanEck Biotech ETF (BBH) position steady in Q2 2026 at 675 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #2808.

Fifth Third Bancorp first reported a position in BBH in Q2 2015 and has held it in 3 quarters since. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

Fifth Third Bancorp held 675 shares of VanEck Biotech ETF worth $137K as of Q2 2026.
Fifth Third Bancorp left its VanEck Biotech ETF share count unchanged in Q2 2026.
VanEck Biotech ETF made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #2808 holding.
Fifth Third Bancorp first reported a position in VanEck Biotech ETF in Q2 2015 and has held it in 3 quarters since.
110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.